Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Primary Peritoneal Carcinoma Patient Treated with Paclitaxel/Carboplain Regimen Combined with Traditional Korean Medicine on the Improvement of Quality of Life

Paclitaxel/Carboplain과 한의 치료를 병행한 원발성 복막암종 환자의 삶의 질 개선에 대한 증례보고

  • Song, Si-yeon (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Ha, Su-jeong (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Park, So-jung (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Jeon, Hyung-joon (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Lee, Yeon-weol (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Cho, Chong-kwan (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Yoo, Hwa-seung (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University)
  • 송시연 (대전대학교 둔산한방병원 동서암센터) ;
  • 하수정 (대전대학교 둔산한방병원 동서암센터) ;
  • 박소정 (대전대학교 둔산한방병원 동서암센터) ;
  • 전형준 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터)
  • Received : 2018.12.03
  • Accepted : 2018.12.18
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study is to report the therapeutic possibility of a primary peritoneal carcinoma (PPC) patient with Traditional Korean Medicine (TKM). Methods: A 37 years old female patient diagnosed with PPC suffered from operation site pain, neck pain, nausea, headache and fatigue after undergoing operation and chemotherapy (Paclitaxel/Carboplain). The patient was treated with acupuncture, pharmacoacupuncture, moxibution and herbal medicine. Laboratory study and National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0 were used to evaluate the safety and adverse events of treatments. The performance status was measured by Eastern Cooperative Oncology Group (ECOG) scale. Results: After treatments, cancer did not show any progression. Related symptoms such as postoperative pain, nausea, fatigue and quality of life have improved. Conclusion: This case study implies that TKM may have therapeutic possibility in treating PPC patient.

Keywords

HJJJCF_2018_v23n2_27_f0001.png 이미지

Figure 1. Imaging Examinations

Table 1. Laboratory Findings

HJJJCF_2018_v23n2_27_t0001.png 이미지

Table 2. The composition of Herbal medicine and Pharmacopuncture

HJJJCF_2018_v23n2_27_t0002.png 이미지

Table 3. Symptom and Quality of life Changes During Treatment

HJJJCF_2018_v23n2_27_t0003.png 이미지

References

  1. Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, Bloss L, DiSaia P. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 50(3):347-351, 1993. https://doi.org/10.1006/gyno.1993.1223
  2. Goodman MT, Shvetsov YB. Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 18(1):132-139, 2009. https://doi.org/10.1158/1055-9965.EPI-08-0771
  3. National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.5.0, 2017. Available from https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/
  4. Gwak JI, Suh SY. The Assessment Tools in Palliative Medicine. Korean J Hosp Palliat Care 1;12(4):177-193, 2009.
  5. Cobb LP, Gaillard S, Wang Y, Shih IM, Secord AA. Adenocarcinoma of Mullerian origin:review of pathogenesis, molecular biology, and emerging treatment paradigms. Gynecol Oncol Res Pract. 2:1, 2015. https://doi.org/10.1186/s40661-015-0008-z
  6. Bae KR, Kim, JH, Park JH, Park SJ, Kang HJ, Cho CK, Yoo HS. Two-cases of Reduction of Side Effects of Surgery and Radiation Therapy in Retroperitoneal Liposarcoma Treated with Traditional Korean Medicine. J of Kor. Traditional Oncology 20(2):37-49, 2015. https://doi.org/10.15432/JKTO.2015.20.2.037
  7. Park JW, Yoon J, Cho CK, Lee YW, Yoo HS. Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus. Chin J Integr Med 20(1):49-55, 2014. https://doi.org/10.1007/s11655-012-1084-0
  8. Yim MH, Shin JW, Son JY, Oh SM, Han SH, Cho JH, Yoo HS, Lee YW, Son CG. Soluble components of Hericium erinaceum induce NK cell activation via production of interleukin-12 in mice splenocytes. Acta Pharmacol Sin 28(6):901-907, 2007. https://doi.org/10.1111/j.1745-7254.2007.00577.x
  9. Khan N, Afaq F, Syed DN, Mukhtar H. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 29(5):1049-1056, 2008. https://doi.org/10.1093/carcin/bgn078
  10. Suh Y, Afaq F, Johnson JJ, Mukhtar H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis 30(2):300-307, 2009. https://doi.org/10.1093/carcin/bgn269